Scientists have found that glucose plays a significant role in how the brain functions.

Published Date: 26 Apr 2023

Nearly a quarter of the body's sugar energy, or glucose, is consumed daily by the human brain, which also has a sweet tooth. Now, scientists from the Gladstone Institutes and UC San Francisco (UCSF) have provided fresh insight into how.

Read Full News

Latest News

CGM Reduces Complications, Mortality in T1D

Continuous glucose monitoring was associated with substantial reductions in diabetes-related complications and mortality in adults with type 1 diabetes in a large national study.

Diabetes Linked to Increased Cancer Risk in Hispanic Adults

Researchers determine time-varying diabetes measures and cancer incidence over time from a US multisite, prospective cohort study involving 16,415 Hispanic and Latino adults aged 18-74 years.

A Practical Guide to Make Digital Tools Work With GLP-1s

The learning curve can be steep for patients trying apps, wearables, and telehealth platforms. Your expertise is needed.

GLP-1s Curb Hunger; Snacks Keep Blood Sugar Stable

If three meals a day is too much, patients can turn to healthy snacks.

Hypothyroidism Drug May Cause Psychiatric Morbidity

The addition of liothyronine to levothyroxine treatment is associated with a higher risk for psychiatric morbidity in patients with autoimmune hypothyroidism.

Maternal Overnutrition Linked to Obesity in Adult Offspring

Maternal overnutrition is associated with a higher likelihood of obesity in adult offspring, with effects persisting into adulthood and being more pronounced in women.

Todays Updates

Nonpharmacologics May Reduce Anxiety, Depression in SUD

Neuromodulation, mind-body therapy, and other nonpharmacologic interventions are linked to improved psychiatric symptoms in people with SUD, a meta-analysis shows.

Revolutionary Cancer Tx Could Transform Autoimmune Disease

Researchers are testing CAR T-cell therapy as a way to reset the immune system in lupus, Graves’ disease and other conditions where the body’s defenses go rogue.

Todays Updates

Nonpharmacologics May Reduce Anxiety, Depression in SUD

Neuromodulation, mind-body therapy, and other nonpharmacologic interventions are linked to improved psychiatric symptoms in people with SUD, a meta-analysis shows.

Revolutionary Cancer Tx Could Transform Autoimmune Disease

Researchers are testing CAR T-cell therapy as a way to reset the immune system in lupus, Graves’ disease and other conditions where the body’s defenses go rogue.

Latest News

Continuous glucose monitoring was associated with substantial reductions in diabetes-related complications and mortality in adults with type 1 diabetes in a large national study.

Researchers determine time-varying diabetes measures and cancer incidence over time from a US multisite, prospective cohort study involving 16,415 Hispanic and Latino adults aged 18-74 years.

The learning curve can be steep for patients trying apps, wearables, and telehealth platforms. Your expertise is needed.

If three meals a day is too much, patients can turn to healthy snacks.

The addition of liothyronine to levothyroxine treatment is associated with a higher risk for psychiatric morbidity in patients with autoimmune hypothyroidism.

Maternal overnutrition is associated with a higher likelihood of obesity in adult offspring, with effects persisting into adulthood and being more pronounced in women.

News All Time

Menopause Symptoms Worse in Women With Abdominal Obesity

Women with abdominal obesity report a higher burden of certain menopausal symptoms and exhibit a distinct pattern of symptom interrelationships relative to women without abdominal obesity.

Can Lower-Dose Tirzepatide Keep Weight Off?

New trial data suggest some patients may maintain meaningful weight loss after stepping down from the maximum dose of tirzepatide.

Pesticides May Help Explain Rising Early-Onset CRC Rates

A study linked a common herbicide to rising early-onset colorectal cancer, using DNA methylation to trace lifelong exposures rather than relying on patient recall.

Restarting GLP-1s After Stopping: How to Counsel Patients

Many patients taking GLP-1 RAs for weight loss discontinue within the first year. How can clinicians support long-term success with these drugs?

Exclusive-FDA Drug Center Head Expected to Leave After Commissioner's Exit, Sources Say

The acting head of the U.S. Food and Drug Administration's drug center, Tracey Beth Hoeg, is expected to leave the agency just days after Commissioner Marty ⁠Makary...

Implanted Islet Cell Device Could Control Glucose for Weeks

Researchers developed a battery-free device the size of a coin that can deliver islet cells in the body and keep them healthy, no immunosuppression required.

US Cancer Clinics Scramble to Get Experimental Revolution Medicines Pancreatic Cancer Drug

U.S. cancer centers are scrambling to enroll patients in an early access program for a highly promising pancreatic cancer drug from Revolution Medicines while they await...

Can GLP-1 Drugs Improve Breast Cancer Survival?

A ‘big’ data study links the diabetes and weight-loss drugs to better long-term survival after breast cancer. Critics are unconvinced.

Blame for the Obesity Epidemic Falls on Food Industry

The rise of new weight-loss drugs could help reframe obesity as a societal failure driven by the food industry, rather than an individual failing rooted in lack of willpower.

EyePoint's Late-stage Eye Drug Trials to Continue After Safety Panel Review

EyePoint said on Thursday an independent safety committee found no new concerns in two late-stage trials ⁠of its experimental eye disease drug Duravyu and recommended the...

Can Gut Bacterium Supplement Lead to Less Weight Regain?

Daily supplementation with pasteurized Akkermansia muciniphila MucT after weight loss leads to less weight regain than placebo in adults with overweight or obesity.

Stress, BMI Linked to Earlier Puberty in Girls

Higher levels of non-estrogen hormones, along with stress and elevated BMI, are linked to earlier breast development in girls.

Patients Over 65 With Obesity Respond Well to Semaglutide

In a pooled analysis of the STEP trials, semaglutide produced substantial weight loss and cardiometabolic improvements in adults aged 65 years or older.

Did Hyperglycemia Affect Inavolisib-Efficacy in BC Patients?

Exploratory data show inavolisib benefits persist regardless of hyperglycemia in PIK3CA-mutated breast cancer, with numerically better outcomes among patients who develop the metabolic side effect.

As GLP-1 Uptake Rises, Metabolic Surgery Rates Decline

Metabolic bariatric surgery use declined by 34.1% from 2022 through 2024, whereas GLP-1 prescriptions increased by more than 140% during the same period.

How Bariatric Surgery Shapes IBD Risk Over Time in Obesity

In patients with severe obesity, metabolic and bariatric surgery was linked to a lower risk for inflammatory bowel disease within 3 years but a higher risk over longer follow-up.

Recommended News For You

GuCS Future Focus: Future Focus from the Genitourinary Cancers Symposium

Another KRAS Inhibitor Scores an Early Win in Advanced Non-Small Cell Lung Cancer

Research indicates that extended PSMA therapy is safe and effective for patients with prostate cancer.

ASCO: GLP-1 receptor agonists may reduce risk for obesity-related cancer, all-cause death

CAR Natural Killer Cell Therapy Shows Promise in B-Cell Lymphomas

Teenagers Frequently Use Delta-8 THC; New Drug-Coated Balloon Treats Blocked Stents.

Study finds higher breast cancer rates in areas with more air pollution

Recommended Articles For You

The Pivotal Role of Telomerase in Breast Cancer Therapy Resistance and Treatment Strategies 

The Statistical Horizon of Colorectal Cancer: From Global Trends to Precision Therapies and Colorectal Cancer 2025 Forecasts 

Partial Gland Ablation in Prostate Cancer: Oncologic Outcomes in Intermediate-Risk Cases 

The Unfolding Revolution of Precision Medicine, Immunotherapy, and Digital Transformation in Medical Oncology 2025 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Celebrity Cancers Stoking Fear? Cisplatin Shortage Ends; Setback for Anti-TIGIT

2.

Promising OS at 5 Years With Chemo-Free Combo in Urothelial Cancer

3.

Resection for Early Liver Cancer Tied to Improved Survival.

4.

Study: Pre-operative THP leads to pCR in 64% of early-stage HER2+ ER- breast cancer patients

5.

Prior authorizations draining time, energy from many cancer patients

1.

Unlocking the Benefits of Cyramza: A New Frontier in Cancer Treatment

2.

AI-Driven Chemotherapy: Transforming Cancer Care with Precision and Efficiency

3.

Understanding Axitinib: What You Need To Know For Your Treatment Plan

4.

Understanding Extramammary Paget's Disease: Causes, Symptoms and Treatment Options

5.

Respiratory Ramifications of Systemic Disease: A Comprehensive Review

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Understanding the causes of anemia in adults beyond nutritional deficiencies

2.

Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part II

3.

Navigating the Complexities of Ph Negative ALL - Part V

4.

Targeting Oncologic Drivers with Dacomitinib: A New Approach to Lung Cancer Treatment

5.

Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part VI

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot